Navigation Links
Indian Scientists Develop Dipstick Test for Dengue

Indian researchers have developed simple, safe and cost-effective dipstick for the early detection of dengue fever. The researchers say its low cost, sensitivity and ease of// use make it better than current tests for dengue.

Nagesh Tripathi and colleagues at the India-based Defence Research and Development Establishment developed a way to efficiently produce a protein that the dengue virus uses.

The protein was incorporated into a dipstick that shows a brown dot if a patient's blood sample contains antibodies to the virus — indicating an infection.

The team is yet to work out how much the dipstick will cost commercially, and say that further testing of how the dipstick works if a patient has another viral infection — such as typhoid or malaria — is necessary.

Dengue is a mosquito-borne viral disease affecting several tropical and subtropical regions of the world. It causes an estimated 100 million infections every year, with no effective vaccine against it.

While the disease itself is rarely fatal, a complication known as dengue haemorrhagic fever kills 20 per cent of victims if they do not receive treatment.

Dengue has recently undergone a dramatic expansion in several parts of Southeast Asia (see A killer arises: the global resurgence of dengue), making early diagnosis extremely important for controlling outbreaks.

The research was published online last week (27 January) in Biotechnology Progress.

Source-Bio-Bio Technology
SI
'"/>




Page: 1

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... to prep patients for colonoscopy at the HyGIeaCare® Center that is to be ... FL. , The HyGIeaCare® Prep, cleared by the U.S. Food and ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion ... to Walk with God #TruthwithGrace” is the creation of published author Lea Michelle ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of Saints: A ... God in congregations across the United States. “The Communion of Saints” is ... who has served congregations in seven states throughout his long career of devotion ...
(Date:3/23/2017)... ... , ... A recent report from the National Council on Teacher Quality (NCTQ) ... suggests, based on a review of GPA and SAT/ACT requirements at 221 institutions in ... It argues that this higher bar should be set by states, by the Council ...
(Date:3/23/2017)... TX (PRWEB) , ... March 23, 2017 , ... ... clinic, located at 960 Gruene Road in Building 2. The clinic is the group’s ... Andrew Bennett, PT, says opening the company’s second New Braunfels location brings things full ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... ShangPharma, a leading life science ... development and discovery services, technology, and investment ... today the intent for a strategic corporate ... the Contract Research Organizations (CRO) and Contract ... entities include ChemPartner Shanghai, ChemPartner Fengxian, ChemPartner ...
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com ... has been growing rapidly as the global sales of Adcetris and ... growth in the antibody drug conjugates market is driven by large ... cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, ...
(Date:3/24/2017)... 24, 2017  Eli Lilly and Company (NYSE: ... invest $850 million in its U.S. operations in ... U.S. enterprise, including research laboratories, manufacturing sites, and ... driven by demand for Lilly products, as well ... development targeting cancer, pain, diabetes and other unmet ...
Breaking Medicine Technology: